
Pei Wang, PhD
About Me
Dr. Wang is a Professor of Genetics and Genomic Sciences. She received her Ph.D. in Statistics from Stanford University in 2004. Between 2004-2013, she served as a faculty in Fred Hutchinson Cancer Research Center and University of Washington, Seattle, WA. In Oct 2013, Dr. Wang joined the faculty of Icahn School of Medicine at Mount Sinai's Department of Genetics and Genomics. Dr. Wang’s research work has been focused on developing statistical and computational methods to address scientific questions based on data from high throughput biology/genetics experiments. Dr. Wang is a member of the Icahn Genomics Institute.
Language
English
Position
PROFESSOR | Genetics and Genomic Sciences
Education
BS, Peking University
PhD, Stanford University
Research
Publications
Selected Publications
- Integrative proteogenomic analysis provides molecular insights and clinical significance in gallbladder cancer. Zile Fu, Yuanli Song, Fen Liu, Lv Chen, Shangli Cai, Peng Cui, Guoqiang Wang, Wenchuan Xie, Shu Zhang, Li Ding, Pei Wang, Bing Zhang, Henry Rodriguez, Feiling Feng, Xufeng Zhang, Wei Gong, Qiang Gao, Daming Gao, Hu Zhou, Jia Fan. Cancer Cell
- Establishing the relationship between brain cellular senescence and brain structure. Anina N. Lund, Brian H. Kopell, Negar Golestani, Eric Vornholt, Ryan C. Thompson, Lora E. Liharska, Yuyang Luo, Esther Cheng, You Jeong Park, Brian Fennessy, Lilian Wilkins, Deepak A. Kaji, Hannah Silk, Kimia Ziafat, Alice Hashemi, Emily Moya, Claudia Feng, Lisa M. Linares, Ariela Buxbaum Grice, Sabrina Xie, Marysia Kolbe Rieder, Joseph Scarpa, Prashant Kota, Vanessa Cohen, Brendan Sullivan, Punit Shah, Weiping Ma, Jessica S. Johnson, Gregory M. Miller, Richard Searfoss, Nischal Mahaveer Chand, Pei Wang, Girish N. Nadkarni, Niven R. Narain, Eric J. Nestler, Michael A. Kiebish, Eric E. Schadt, Alexander W. Charney, Noam D. Beckmann. Cell
- sCCIgen: a high-fidelity spatially resolved transcriptomics data simulator for cell–cell interaction studies. Xiaoyu Song, Joselyn C. Chavez-Fuentes, Weiping Ma, Weijia Fu, Sujung Crystal Shin, Pei Wang, Guo Cheng Yuan. Genome Biology
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Wang did not report having any of the following types of financial relationships with industry and other outside entities during 2025 and/or 2026: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.